SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-054099
Filing Date
2024-04-29
Accepted
2024-04-29 16:34:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm242729d3_defa14a.htm DEFA14A 13501
2 GRAPHIC tm242729d3_defa14aimg001.jpg GRAPHIC 215130
3 GRAPHIC tm242729d3_defa14aimg002.jpg GRAPHIC 197708
  Complete submission text file 0001104659-24-054099.txt   583486
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37990 | Film No.: 24891636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)